Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a multiple-award Federal Supply Schedule (FSS) contract by the U.S. Department of Veterans Affairs (VA) for Critical Analyzers, Laboratory (FSS-66-III). This contract has a ceiling value of $51.1 million and runs through April 14, 2026.
Through this contract, Abbott Molecular provides a range of molecular diagnostics equipment, reagents, and testing services to support federal healthcare programs, particularly at VA facilities. Task orders issued under the contract cover products and services such as COVID-19 test kits, reagents for clinical chemistry analyzers, viral load testing, and reagents for HIV and Hepatitis C testing. These task orders, valued from tens of thousands to millions of dollars, utilize firm fixed-price pricing and do not include small business set-asides. The contract allows the VA and other federal agencies to efficiently acquire critical laboratory supplies and diagnostic capabilities from an experienced medical device and diagnostics provider.
Generated 2/5/25, 9:06 AM